Visit Gigbucks Today


GlaxoSmithKline confirms Pronova BioPharma reaches agreement with Apotex regarding Lovaza™ US patent litigation (Webwire)

Litigation continues between Pronova BioPharma and two other generic challengers - - GlaxoSmithKline (GSK), which has the marketing rights for Lovaza (omega-3-acid ethyl esters) in the US and Puerto Ri...
Share With Friends: Share on FacebookTweet ThisPost to Google-BuzzSend on GmailPost to Linked-InSubscribe to This Feed | Rss To Twitter | Industry - Pharmaceutical Stories, RSS Feeds and Widgets via Feedzilla.